Imatinib mesylate (STI571)-induced cell edge translocation of kinase-active and kinase-defective abelson kinase: Requirements of myristoylation and src homology 3 domain

Molecular Pharmacology

Volumn 75, Issue 1, 2009, Pages 75-84

  Fujita, Akiko ^a   Shishido, Tomoyuki ^b   Yuan, Yunfeng ^a   Inamoto, Eiji ^a   Narumiya, Shuh ^a   Watanabe, Naoki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; GREEN FLUORESCENT PROTEIN; IMATINIB; PROTEIN SH3; BCR ABL PROTEIN; FLUORESCENT DYE; MYRISTIC ACID; PHOSPHOTRANSFERASE; PIPERAZINE DERIVATIVE; PROTEIN TYROSINE KINASE; PYRIMIDINE DERIVATIVE;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FIBROBLAST; LAMELLIPODIUM; MYRISTYLATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; QUANTITATIVE ANALYSIS; ANIMAL; CELL CULTURE; CULTURE MEDIUM; DOSE RESPONSE; DRUG ANTAGONISM; GENETIC TRANSFECTION; GENETICS; METABOLISM; MOUSE; POINT MUTATION; SRC HOMOLOGY DOMAIN; XENOPUS LAEVIS;

ANIMALS; CELLS, CULTURED; CULTURE MEDIA, SERUM-FREE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FLUORESCENT DYES; FUSION PROTEINS, BCR-ABL; GREEN FLUORESCENT PROTEINS; MICE; MYRISTIC ACID; PHOSPHOTRANSFERASES; PIPERAZINES; POINT MUTATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS C-ABL; PYRIMIDINES; SRC HOMOLOGY DOMAINS; TRANSFECTION; XENOPUS LAEVIS;

EID: 58849108624     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.051706     Document Type: Article

References (45)

1. Azam M, Latek RR, and Daley GQ (2003) Mechanisms of autoinhibition and STI- 571/imatinib resistance revealed by mutagenesis of BCR-ABL. Cell 112:831-843.
2. Barilá D and Superti-Furga G (1998) An intramolecular SH3-domain interaction regulates c-Abl activity. Nat Genet 18:280-282.
3. Brasher BB and Van Etten RA (2000) c-Abl has high intrinsic tyrosine kinase activity that is stimulated by mutation of the Src homology 3 domain and by autophosphorylation at two distinct regulatory tyrosines. J Biol Chem 275:35631-35637.
4. Burton EA, Oliver TN, and Pendergast AM (2005) Abl kinases regulate actin comet tail elongation via an N-WASP-dependent pathway. Mol Cell Biol 25:8834-8843.
5. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, and Tsien RY (2002) A monomeric red fluorescent protein. Proc Natl Acad Sci USA 99: 7877-7882.
6. Cicchetti P, Ridley AJ, Zheng Y, Cerione RA, and Baltimore D (1995) 3BP-1, an SH3 domain binding protein, has GAP activity for Rac and inhibits growth factor- induced membrane ruffling in fibroblasts. EMBO J 14:3127-3135.
7. Corbin AS, Buchdunger E, Pascal F, and Druker BJ (2002) Analysis ofthe structural basis of specificity of inhibition of the Abl kinase by STI571. J Biol Chem 277: 32214-32219.
8. Dai Z, Kerzic P, Schroeder WG, and McNiece IK (2001) Deletion of the Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abl prevents Abl interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis. J Biol Chem 276:28954-28960.
9. Dai Z and Pendergast AM (1995) Abi-2, a novel SH3-containing protein interacts with the c-Abl tyrosine kinase and modulates c-Abl transforming activity. Genes Dev 9:2569-2582.
10. de Klein A, van Kessel AG, Grosveld G, Bartram CR, Hagemeijer A, Bootsma D, Spurr NK, Heisterkamp N, Groffen J, and Stephenson JR (1982) A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia. Nature 300:765-767.
11. Dorey K, Engen JR, Kretzschmar J, Wilm M, Neubauer G, Schindler T, and Superti- Furga G (2001) Phosphorylation and structure-based functional studies reveal a positive and a negative role for the activation loop of the c-Abl tyrosine kinase. Oncogene 20:8075-8084.
12. Druker BJ, Tamura S, Buchdunger E, Ohno S, Segal GM, Fanning S, Zimmermann J, and Lydon NB (1996) Effects of a selective inhibitor ofthe Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat Med 2:561-566.
13. Eden S, Rohatgi R, Podtelejnikov AV, Mann M, and Kirschner MW (2002) Mechanism of regulation of WAVE1-induced actin nucleation by Rac1 and Nck. Nature 418:790-793.
14. Gangal M, Clifford T, Deich J, Cheng X, Taylor SS, and Johnson DA (1999) Mobilization of the A-kinase N-myristate through an isoform-specific intermolecular switch. Proc Natl Acad Sci U S A 96:12394-12399.
15. Hantschel O, Nagar B, Guettler S, Kretzschmar J, Dorey K, Kuriyan J, and Superti- Furga G (2003) A myristoyl/phosphotyrosine switch regulates c-Abl. Cell 112:845-857.
16. Hantschel O, Wiesner S, Güttler T, Mackereth CD, Rix LL, Mikes Z, Dehne J, Görlich D, Sattler M, and Superti-Furga G (2005) Structural basis for the cytoskel- etal association of Bcr-Abl/c-Abl. Mol Cell 19:461-473.
17. Higashida C, Miyoshi T, Fujita A, Oceguera-Yanez F, Monypenny J, Andou Y, Narumiya S, and Watanabe N (2004) Actin polymerization-driven molecular movement of mDia1 in living cells. Science 303:2007-2010.
18. Jackson P and Baltimore D (1989) N-terminal mutations activate the leukemogenic potential of the myristoylated form of c-abl. EMBO J 8:449-456.
19. Jin H and Wang JY (2007) Abl tyrosine kinase promotes dorsal ruffles but restrains lamellipodia extension during cell spreading on fibronectin. Mol Biol Cell 18:4143-4154.
20. Kantarjian H, Sawyers C, Hochhaus A, Guilhot F, Schiffer C, Gambacorti-Passerini C, Niederwieser D, Resta D, Capdeville R, Zoellner U, et al. (2002) Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia. N Engl J Med 346:645-652.
21. Kurokawa K, Mochizuki N, Ohba Y, Mizuno H, Miyawaki A, and Matsuda M (2001)A pair of fluorescent resonance energy transfer-based probes for tyrosine phos-phorylation of the CrkII adaptor protein in vivo. J Biol Chem 276:31305-31310.
22. Leng Y, Zhang J, Badour K, Arpaia E, Freeman S, Cheung P, Siu M, and Siminovitch K (2005) Abelson-interactor-1 promotes WAVE2 membrane translocation and Abelson-mediated tyrosine phosphorylation required for WAVE2 activation. Proc Natl Acad Sci U S A 102:1098-1103.
23. Levinson NM, Kuchment O, Shen K, Young MA, Koldobskiy M, Karplus M, Cole PA, and Kuriyan J (2006) A Src-like inactive conformation in the abl tyrosine kinase domain. PLoS Biol 4:e144.
24. Li Y, Clough N, Sun X, Yu W, Abbott BL, Hogan CJ, and Dai Z (2007) Bcr-Abl induces abnormal cytoskeleton remodeling, beta1 integrin clustering and increased cell adhesion to fibronectin through the Abl interactor 1 pathway. J Cell Sci 120:1436-1446.
25. Miyoshi T, Tsuji T, Higashida C, Hertzog M, Fujita A, Narumiya S, Scita G, and Watanabe N (2006) Actin turnover-dependent fast dissociation of capping protein in the dendritic nucleation actin network: evidence of frequent filament severing. J Cell Biol 175:947-955.
26. Nagar B, Hantschel O, Seeliger M, Davies JM, Weis WI, Superti-Furga G, and Kuriyan J (2006) Organization ofthe SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase. Mol Cell 21:787-798.
27. Nagar B, Hantschel O, Young MA, Scheffzek K, Veach D, Bornmann W, Clarkson B, Superti-Furga G, and Kuriyan J (2003) Structural basis for the autoinhibition of c-Abl tyrosine kinase. Cell 112:859-871.
28. Nakagawa H, Miki H, Ito M, Ohashi K, Takenawa T, and Miyamoto S (2001) N-WASP, WAVE and Mena play different roles in the organization of actin cy- toskeleton in lamellipodia. J Cell Sci 114:1555-1565.
29. Pendergast AM (2002) The Abl family kinases: mechanisms of regulation and signaling. Adv Cancer Res 85:51-100.
30. Quintás-Cardama A, Kantarjian H, and Cortes J (2007) Flying under the radar: the new wave of BCR-ABL inhibitors. Nat Rev Drug Discov 6:834-848.
31. Roumiantsev S, Shah NP, Gorre ME, Nicoll J, Brasher BB, Sawyers CL, and Van Etten RA (2002) Clinical resistance to the kinase inhibitor STI-571 in chronic myeloid leukemia by mutation of Tyr-253 in the Abl kinase domain P-loop. Proc Natl Acad Sci U SA99:10700-10705.
32. Schindler T, Bornmann W, Pellicena P, Miller WT, Clarkson B, and Kuriyan J (2000) Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase. Science 289:1938-1942.
33. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, and Tsien RY (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22:1567-1572.
34. ShiY,AlinK,andGoffSP(1995)Abl-interactor-1,anovelSH3proteinbindingtothe carboxy-terminal portion of the Abl protein, suppresses v-abl transforming activity. Genes Dev 9:2583-2597.
35. Suzuki J and Shishido T (2007) Regulation of cellular transformation by oncogenic and normal Abl kinases. J Biochem 141:453-458.
36. Tani K, Sato S, Sukezane T, Kojima H, Hirose H, Hanafusa H, and Shishido T (2003) Abl interactor 1 promotes tyrosine 296 phosphorylation of mammalian enabled (Mena) by c-Abl kinase. J Biol Chem 278:21685-21692.
37. Ting AY, Kain KH, Klemke RL, andTsienRY(2001) Genetically encoded fluorescent reporters of protein tyrosine kinase activities in living cells. Proc Natl Acad Sci USA98:15003-15008.
38. Van Etten RA, Debnath J, Zhou H, and Casasnovas JM (1995) Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability ofc-abl in vivo and abolishes binding of proline-rich ligands in vitro. Oncogene 10:1977-1988.
39. Wang JY (2004) Controlling Abl: auto-inhibition and co-inhibition? Nat Cell Biol 6:3-7.
40. Watanabe N and Mitchison TJ (2002) Single-molecule speckle analysis of actin filament turnover in lamellipodia. Science 295:1083-1086.
41. Welch PJ and Wang JY (1993) A C-terminal protein-binding domain in the retino-blastoma protein regulates nuclear c-Abl tyrosine kinase in the cell cycle. Cell 75:779 -790.
42. Wen ST and Van Etten RA (1997) The PAG gene product, a stress-induced protein with antioxidant properties, is an Abl SH3-binding protein and a physiological inhibitor of c-Abl tyrosine kinase activity. Genes Dev 11:2456-2467.
43. Woodring PJ, Hunter T, and Wang JY (2001) Inhibition of c-Abl tyrosine kinase activity by filamentous actin. J Biol Chem 276:27104-27110.
44. Woodring PJ, Hunter T, and Wang JY (2003) Regulation of F-actin-dependent processes by the Abl family of tyrosine kinases. J Cell Sci 116:2613-2626.
45. Woodring PJ, Litwack ED, O'Leary DD, Lucero GR, Wang JY, and Hunter T (2002) Modulation of the F-actin cytoskeleton by c-Abl tyrosine kinase in cell spreading and neurite extension. J Cell Biol 156:879-892.